Delivery Order SPE2DB24D2018-SPE2DB25FWVU9
- Not listed
- This is a $7,685.32 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LONSURF 15 MG-6.14 MG tablets, which are used for medical treatment. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
- The Defense Logistics Agency awarded a $6,760.14 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Lonsurf (20 mg-8.19 mg tablets) in quantities of 40 units. This is a firm fixed price contract with an ultimate completion date of August 12, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and will be...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of LONSURF 20 MG-8.19 MG tablets. The firm-fixed-price contract has a ceiling value of $6,760.14 and a completion date of April 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of LONSURF 20 MG-8.19 MG tablets. The $8,531.96 firm-fixed-price contract has an ultimate completion date of October 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of medical...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LONSURF 20 MG-8.19 MG TABLET 40S, a pharmaceutical product, with a ceiling value of $13,520.28. The contract is a firm fixed-price, non-set-aside delivery order with a performance period through July 10, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of LONSURF 20 MG-8.19 MG TABLET 20S, a prescription drug product, with a ceiling value of $6,429.34 and a period of performance through October 1, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen, through its Corporate Office division, has been awarded numerous...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LONSURF 20 MG-8.19 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $10,173.33 and a completion date of February 28, 2025. The award was made on February 6, 2025, and there was no set-aside designation used. AmerisourceBergen holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LONSURF 20 MG-8.19 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price and a ceiling value of $10,173.33. The period of performance extends to July 7, 2025. This contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,378.67 firm fixed price delivery order to Amerisourcebergen Drug Corp, a leading pharmaceutical distributor, for the supply of LONSURF 20 MG-8.19 MG TABLET 40S. This order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential total value of $999,999,999.00 and a period of performance through December 31, 2025. The IDC serves as the primary vehicle for...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,092.24, is for the delivery of LONSURF 15 MG-6.14 MG tablets. The contract has an ultimate completion date of April 22, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWVU9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $12.7K to AmerisourceBergen Drug Corp for LONSURF 20 mg-8.19 mg tablets (60-count supply). This non-set-aside, firm fixed-price delivery order was awarded on July 24, 2025, with completion scheduled for August 14, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. LONSURF is a prescription oncology medication used in cancer treatment, reflecting the company's role as a critical pharmaceutical supplier for federal military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.9M and extends through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a comprehensive range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. Through competitively awarded contracts, AmerisourceBergen demonstrates its capability to fulfill federal medical procurement requirements across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.7k | 7/24/25 |